Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antisense oligonucleotide therapy for TTR amyloidosis

1 Jun 2011

Abstract excerpt

Abstract: Orthotopic liver transplantation (OLT) that eliminates hepatic production of variant transthyretin (TTR) in patients with hereditary TTR amyloidosis is the only specific therapy that has ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Neuroendocrine Tumor Research Advances
Share to Pneumocystis jirovecii pneumonia detection and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21838433
DOI: 10.3109/13506129.2011.574354021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antisense oligonucleotide therapy for TTR amyloidosisPMID 21838433Read ↗

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides.Semantic proximity Read ↗

TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patientsSemantic proximity Read ↗

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatmentsSemantic proximity Read ↗

Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotidesSemantic proximity Read ↗

Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin AmyloidosisSemantic proximity Read ↗

Treating hereditary transthyretin amyloidosis: Present & future challenges.Semantic proximity Read ↗

RNA Targeting and Gene Editing Strategies for Transthyretin AmyloidosisSemantic proximity Read ↗

Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathySemantic proximity Read ↗

Transthyretin Amyloid Cardiomyopathy Treatment: An Updated ReviewSemantic proximity Read ↗

RNA-targeting and gene editing therapies for transthyretin amyloidosisSemantic proximity Read ↗

Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.